
Meta-Analysis Confirms the Unlikelihood of GLP-1 RA Raising Suicidal Risk
Yet another study confirmed that peptide-1 receptor agonist (GLP-1 RA) is unlikely to increase suicide-related adverse events.1 In July 2024, a study was published that reported GLP-1 RAs do not increase the risk for suicidal thoughts or behaviors.2 People …